Background There has been burgeoning interest in quality of life (QoL) in inflammatory
bowel disease (IBD) in recent decades, with hundreds of studies each year now assessing …

Therapeutic advances in the management of IBD have led to a paradigm shift in the
assessment of IBD disease activity. Beyond clinical remission, objective assessment of …

Background & Aims There is limited evidence that a diet low in fermentable
oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) reduces gut …

Background There is increasing international interest in the concept of mental well-being
and its contribution to all aspects of human life. Demand for instruments to monitor mental …

Background There is considerable interest in the possible importance of the gut microflora in
the pathophysiology of the inflammatory bowel diseases (IBD) ulcerative colitis (UC) and …

Background Infliximab and ciclosporin are of similar efficacy in treating acute severe
ulcerative colitis, but there has been no comparative evaluation of their relative clinical …

The Food and Drug Administration (FDA) is moving from the Crohn's Disease Activity Index
to patient-reported outcomes (PROs) and objective measures of disease, such as findings …

Abstract Background and Aims Success in delivering value-based healthcare involves
measuring outcomes that matter most to patients. Our aim was to develop a minimum …

Introduction The use of patient reported outcome measures to support routine inflammatory
bowel disease (IBD) care is not widespread and suggests that existing questionnaires lack …

Introduction Crohn's perianal fistulas are challenging for patients and clinicians. Many do not
respond to available treatments and despite recommendations by a global consensus, there …